VPTDF (VentriPoint Diagnostics) Interest Expense: $-0.38 Mil (TTM As of Dec. 2025)

What is VentriPoint Diagnostics Interest Expense?

VentriPoint Diagnostics VPTDF 8 Interest Expense is $-0.38 Mil as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. VentriPoint Diagnostics's interest expense for the three months ended in Dec. 2025 was $ -0.13 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.38 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. VentriPoint Diagnostics's Operating Income for the three months ended in Dec. 2025 was $ -0.54 Mil. VentriPoint Diagnostics's Interest Expense for the three months ended in Dec. 2025 was $ -0.13 Mil. VentriPoint Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

VentriPoint Diagnostics (OTCPK:VPTDF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

VentriPoint Diagnostics's Interest Expense for the three months ended in Dec. 2025 was $-0.13 Mil. Its Operating Income for the three months ended in Dec. 2025 was $-0.54 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was $0.08 Mil.

VentriPoint Diagnostics's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

VentriPoint Diagnostics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

VentriPoint Diagnostics Interest Expense Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Interest Expense can be seen below:

VentriPoint Diagnostics Interest Expense Chart

VentriPoint Diagnostics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

-0.04

-0.13

-0.38

VentriPoint Diagnostics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Interest Expense	Get a 7-Day Free Trial															-0.05	-0.08	-0.09	-0.09	-0.13

8GF Score

VentriPoint Diagnostics Ltd VPTDF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

VentriPoint Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.38 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.38 Mil mean?

VentriPoint Diagnostics (VPTDF) has a Interest Expense of $-0.38 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on VentriPoint Diagnostics and its competitors.

Is VentriPoint Diagnostics' Interest Expense too high?

VentriPoint Diagnostics' current Interest Expense is $-0.38 Mil. Overall, VentriPoint Diagnostics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.

How does VentriPoint Diagnostics' Interest Expense compare to ABT and SYK?

VentriPoint Diagnostics' Interest Expense of $-0.38 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Interest Expense is $-0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is VentriPoint Diagnostics stock overvalued right now?

VentriPoint Diagnostics (VPTDF) has a current Interest Expense of $-0.38 Mil. The current Interest Expense is $-0.38 Mil. VentriPoint Diagnostics' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Interest Expense is $-0.38 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSXV:ASG TSXV:MDX TSXV:CNVI TSXV:VVTM TSXV:PAIN TSXV:FREQ TSXV:CHER XCNQ:QAI TSXV:NGMD TSXV:THRM ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges VPT:Canada

Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.

8GF Score

Get the complete analysis for VPTDF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08

Price

View VPTDF Analysis

See Interest Expense data for all stocks →